Healthcare
Regenerative Medical Technology Group Inc.(RMTG)
Live Price
Offline$0.0414
+31.85% today
1Y Change
+48.15%
Window
Jun 23, 2025 โ Jun 9, 2026
- Market Cap
- โ
- Revenue Growth
- +70.4%
- EPS Growth
- +44.3%
- Dividend Yield
- 0.0%
Coverage: 243 bars ยท Jun 23, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regenerative Medical Technology Group Inc. (RMTG) is a Healthcare stock with listed on OTC. The stock last traded around $0.04 and up 48.1% across the available one-year price window (Jun 23, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +70.4%, EPS growth of +44.3%, a dividend yield of 0.0%. What stands out right now is revenue +70.4%, EPS +44.3%, free cash flow +178.9% with operating margin -5.3% and ROIC 2.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RMTG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+70.4% vs +7.6% peer median
Operating Margin
Below sector median
-5.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Sep 30, 2023, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +70.4% and EPS at +44.3%, with operating margin around -5.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +59.3% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2023 Sep 30, 2023 | โ | +62.6% | +59.3% | +122.6% |
2023 Jun 30, 2023 | โ | +62.6% | +59.3% | +122.6% |
2023 Mar 31, 2023 | โ | +62.6% | +59.3% | +122.6% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RMTG
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RMTG Max Drawdown
-74.46%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RMTG and SPY.
Company Overview
Regenerative Medical Technology Group Inc.
Other OTC
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
- Leadership
- David Eugene Christensen
- IPO Date
- Sep 13, 1999
- Employees
- 1
- Street Address
- 433 Plaza Real
- Mailing
- Boca Raton, FL, 33432
- Region
- Boca Raton, FL, US
- Reporting Currency
- USD
- Investor Line
- 800 956 3935
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.1
- Price/Book
- โ
Growth
- Revenue
- +70.4%
- EPS
- +44.3%
- Free Cash Flow
- +178.9%
Profitability
- Gross Margin
- 61.7%
- Operating Margin
- -5.3%
- Net Margin
- -140.1%
- ROE
- 24.6%
- ROIC
- 2.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.09
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.